Gossamer Bio Announces Participation in Upcoming Investor Conferences
June 01 2020 - 7:35AM
Business Wire
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage
biopharmaceutical company focused on discovering, acquiring,
developing and commercializing therapeutics in the disease areas of
immunology, inflammation and oncology, today announced its
participation in two upcoming investor conferences. Chief Executive
Officer and Co-Founder Sheila Gujrathi, M.D., will present at the
Jefferies Virtual Healthcare Conference on Thursday, June 4, at
3:00 p.m. ET and at the 41st Annual Goldman Sachs Global Healthcare
Conference on Thursday, June 11, at 2:10 p.m. ET.
Live webcasts of both presentations will be available on the
“Events and Presentations” page in the “Investors” section of the
company’s website at https://ir.gossamerbio.com. Replays of each
webcast will be archived on the company’s website for 90 days
following the presentation.
About Gossamer Bio
Gossamer Bio is a clinical-stage biopharmaceutical company
focused on discovering, acquiring, developing and commercializing
therapeutics in the disease areas of immunology, inflammation and
oncology. Its goal is to be an industry leader in each of these
therapeutic areas and to enhance and extend the lives of patients
suffering from such diseases.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200601005175/en/
For Investors and Media: Bryan Giraudo, Chief Financial
Officer Gossamer Bio Investor Relations ir@gossamerbio.com
Gossamer Bio (NASDAQ:GOSS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gossamer Bio (NASDAQ:GOSS)
Historical Stock Chart
From Jul 2023 to Jul 2024